Modified RSV F proteins and methods of their use
US9717786B2 · kind B2 · utility
7Cited by
4References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2015 |
| Grant date | Aug 1, 2017 |
| Priority date | — |
| Expiry date | Jun 4, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18571
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.